[ad_1]
Scientists from the country’s Food and Drug Administration (FDA) say the vaccine against the new coronavirus, developed by the American pharmaceutical company Modern, is 94 percent effective. They said it on Tuesday. A meeting of the US Vaccine Approval Panel is scheduled for Thursday local time. This information has been reported in the media CNN and BBC.
Deaths by corona in the United States have exceeded three million. The Pfizer-Bioentech crown symbol has been in use since last Monday. The next day, Tuesday, FDA scientists gave good news about the modern vaccine. In a 54-page article, they said that no specific safety risks were found in the modern vaccine. Furthermore, the serious reaction is absolutely negligible.
The FDA has found that the modern vaccine has been given to 30,000 people, with an efficacy of 94.1 percent. Side effects include fever, headache, and muscle and joint pain. The FDA also found these side effects in the Pfizer-Bioentech tick test.
The company will be able to deliver the first shipment of vaccines within 24 hours if the panel of experts and the FDA chief approve emergency use. Their office and factory are in Cambridge, Massachusetts. On the other hand, the Pfizer-Bioentech vaccine is being prepared in several countries, including Germany and Belgium.
Modern vaccines are more likely to be distributed and stockpiled. It can be kept at a temperature of minus 20 degrees Celsius. Which is suitable for general refrigeration. Where the Pfizer-Bioentech vaccine must be kept at a temperature of minus 60 degrees Celsius. Modern vaccines must also be given in two doses. The second dose should be administered 28 days after the first dose.
However, since Moderna was established in 2010, no product has been approved by the FDA. This will be your first product in the United States if the crown ticker is approved. The company’s share price has risen nearly 700 percent recently.
The United States government will receive 200 million doses of the vaccine from the company. Once approved, they will deliver 6 million doses in the first shipment. The Canadian government will take 56 million doses and the UK government has already ordered 7 million doses from Modern. Additionally, Switzerland has asked for Rs 7.5 crore, Japan Rs 5 crore and South Korea Rs 20 crore.
[ad_2]
